Next Generation Gene Therapeutic Inc announced that it has received $10,000,000 in funding led by NetEase, Inc. on October 26, 2021. The transaction included participation from China Creation Ventures, Shunwei Capital, and The Arena Capital. NetEase, Inc. (NasdaqGS:NTES) invested $5,000,000 in the round.